Details for New Drug Application (NDA): 206066
✉ Email this page to a colleague
The generic ingredient in BEPOTASTINE BESILATE is bepotastine besilate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bepotastine besilate profile page.
Summary for 206066
Tradename: | BEPOTASTINE BESILATE |
Applicant: | Apotex |
Ingredient: | bepotastine besilate |
Patents: | 0 |
Suppliers and Packaging for NDA: 206066
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 206066 | ANDA | Apotex Corp. | 60505-6111 | 60505-6111-1 | 1 BOTTLE, DROPPER in 1 CARTON (60505-6111-1) / 5 mL in 1 BOTTLE, DROPPER |
BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 206066 | ANDA | Apotex Corp. | 60505-6111 | 60505-6111-2 | 1 BOTTLE, DROPPER in 1 CARTON (60505-6111-2) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1.5% | ||||
Approval Date: | Mar 5, 2019 | TE: | AT | RLD: | No |
Complete Access Available with Subscription